Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer.

Thierry André,Kai-Keen Shiu,Tae-Won Kim,Benny Vittrup Jensen,Lars Henrik Jensen,Cornelis J. A. Punt,Denis Smith,Rocio Garcia-Carbonero,Manuel Benavides,Peter Gibbs,Christelle De La Fouchardiere,Fernando Rivera,Elena Elez,Johanna C. Bendell,Dung T. Le,Takayuki Yoshino,Eric Van Cutsem,Ping Yang,Mohammed Z.H. Farooqui,Patricia Marinello,Luis A. Diaz

Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer.

2020

Abstract Background Programmed death 1 (PD-1) blockade has clinical benefit in microsatellite-instability–high (MSI-H) or mismatch-repair–deficient (dMMR) tumors after previous therapy. The efficac...

Keywords:

programmed death 1
advanced colorectal cancer
Blockade
Oncology
Pembrolizumab
Microsatellite instability
Internal medicine
Medicine
MEDLINE

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

272

Citations